Monday, 20 February 2017

Nordic Nanovector sees interest in its Non-Hodgkin Lymphoma treatment

OSLO (Reuters) - Norwegian biotech newcomer Nordic Nanovector , which seeks ways to treat blood-related cancers, says other companies are showing interest in buying the firm.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)